PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 77.00
-1.00 (-1.28%)
Apr 30, 2026, 4:14 PM WIB
IDX:MEDS Revenue
In the year 2025, PT Hetzer Medical Indonesia Tbk had annual revenue of 6.63B IDR with 3.73% growth. PT Hetzer Medical Indonesia Tbk had revenue of 1.68B in the quarter ending December 31, 2025.
Revenue
6.63B
Revenue Growth
+3.73%
P/S Ratio
18.15
Revenue / Employee
414.32M
Employees
16
Market Cap
120.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.63B | 238.07M | 3.73% |
| Dec 31, 2024 | 6.39B | -16.33B | -71.87% |
| Dec 31, 2023 | 22.72B | -15.01B | -39.79% |
| Dec 31, 2022 | 37.74B | -38.05B | -50.21% |
| Dec 31, 2021 | 75.79B | -12.00B | -13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Millennium Pharmacon International Tbk | 4.11T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.64T |
| PT Phapros Tbk | 961.30B |
| PT Royal Prima Tbk | 338.91B |
| PT Diagnos Laboratorium Utama Tbk | 166.62B |